Latest news for  (OTC:JEMTF) Stock

WIIM

SMX (Security Matters) shares are trading lower after the company announced a $5.35 million private placement.

OWLT

Owlet shares are trading lower after the company announced te pricing of a $46.6 million offering of 3,135,136 shares at $3.70 per share.

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) with a Buy rating and announces Price Target of $17.

News

Price Target

Initiation

Analyst Ratings

BNTC

Guggenheim Initiates Coverage On Benitec Biopharma with Buy Rating, Announces Price Target of $17

STRM

Streamline Health Solutions shares are trading lower after the ocmpany reported mixed Q2 financial results.

NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) – both heavyweights in the realm of artificial intelligence – saw their market value rise significantly during the midweek session. NVDA stock jumped just over 8% against Tuesday's close, while AMD came shy of hitting 5% up.
According to a Reuters report, the U.S. government is mulling over whether it should give Nvidia the green light to<a href="https://www.reuters.com/technology/us-closer-green-lighting-nvidia-chips-saudi-arabia-semafor-reports-2024-09-11/"> export its advanced graphics processors</a> – the powerful semiconductors undergirding myriad AI platforms – to Saudi Arabia. Doing so would represent a pivot from the Biden administration's curbs on exports of these advanced chips, a move ultimately<a href="https://www.benzinga.com/news/23/10/35258403/team-biden-moves-to-close-loopholes-in-ai-chip-export-regulations-to-china"> meant to counter China's digital ambitions</a>.
Allowing the shipments to go ahead would represent a much-needed boost for NVDA and its ilk. Although both Nvidia and Advanced Micro have enjoyed strong returns over the past year, in the past few months, forward momentum for both enterprises has conspicuously slowed.
Adding to the positive sentiment on Wednesday was news that ChatGPT parent OpenAI may be considering an<a href="https://www.benzinga.com/news/24/09/40825072/openais-valuation-could-skyrocket-to-150b-in-new-fundraising-positioning-it-among-the-worlds-most-va"> equity financing raise of $6.5 billion</a>. Potential investors include Nvidia, along with tech juggernauts Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>). With large language models becoming increasingly popular, greater interest in OpenAI may translate to growth acceleration for NVDA stock.
Nevertheless, not every expert is convinced that the innovation ecosystem will continue marching higher without serious challenges. While certain benchmark players have enjoyed significant gains, companies that primarily focus on elements outside AI – such as traditional software firms – have<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40767784/nvidia-microsofts-ai-rally-hides-tech-sectors-underlying-weakness-warn-experts-ther"> struggled for traction</a>.
What's more, enterprises like workflow management firm Asana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) – which utilizes both AI and big data – have admitted to overhiring and overspending during the early days of the COVID-19 pandemic. The market is now adjusting to current realities, which could potentially put the elevated valuations of certain businesses at risk.
The ETFs: Still, the environment for traders looking to play the trend is a compelling one for financial services firm Direxion. As the provider of myriad leveraged and inverse exchange-traded funds, the company offers traders a convenient way to extract daily profits out of popular stocks and specific sectors. Those bullish on machine intelligence may consider the Direxion Daily AI and Big Data Bull 2X Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIBU#NYSE">AIBU</a>).
On the other hand, those skeptical about AI and the current valuations of certain tech players may opt for the Direxion Daily AI and Big Data Bear 2X Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIBD#NYSE">AIBD</a>). Either way, both ETFs track the daily investment results – 200% in the case of AIBU and 200% of the inverse in the case of AIBD – of the Solactive US AI &amp; Big Data Index.
Investors considering either the AIBU or AIBD should be aware that these funds are designed for exposure lasting no longer than one day (session). Due to the daily compounding effect of volatility, the actual performance of leveraged funds held over the long term can erode significantly from their expected performance.
The AIBU ETF: While the AI and Big Data fund enjoyed an auspicious start during the first half of the year, the second half so far has been met with a higher magnitude of resistance.
<ul>
<li>Speaking of resistance, while AIBU was able to reverse course from its doldrums earlier this month, it's hitting a ceiling at around $27, emblematic of the recent momentum issues stymieing NVDA stock.</li>
<li>Even if AIBU crosses above the $27 resistance line, it must also breach the level hanging just below $29. What's more, the bears have previously troubled the bulls at the $28 line, suggesting significant work to come.</li>
</ul>
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXdp7mKy9TWz55cCMG1MWNIm3_STZgGeC_9Ubap9VIbc0n1kNgN9FdqrA1prTy7hzhNE1auifdlGAJBIwGcs-9UcXJYtRIHhAyVCbljVqbIjO7Qu8zhMoNYT-NLDgdZ_c-6S3ztbD2g38IfcinON8LSSGJY?key=HqYsmPLhKymQBx18pu6WOw" alt="" /></figure>
The AIBD ETF: In a reversal of sentiment, the AIBD ETF struggled during the first half of 2024. However, in the second half, the inverse leveraged fund appears to be finding its footing.
<ul>
<li>As expected, AIBD did not have a great session on Wednesday. However, the one positive is that the $22 support line that it's straddling appears to be a strong one.</li>
<li>Significant volume (relatively speaking) entered the inverse ETF earlier this month, suggesting brewing interest in betting against the popular AI theme.</li>
</ul>
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXdhpiERt0rFhXJtx9l-LYORlKA08gdGuxNr8koOFZFKawLmhwJDwB-_oxVKt2xRqTcwg5KzCGuI5kZCX0fYWrkwDHwFiasiiPmY1VYwEZ27UIxOM8LQdh7qBgw0VSOqI4B5c-nI-XqRlVEvj7FjgHgxYzk?key=HqYsmPLhKymQBx18pu6WOw" alt="" /></figure>
Featured photo by <a href="https://pixabay.com/users/brianpenny-29844978/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=8540922">Brian Penny</a> on <a href="https://pixabay.com//?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=8540922">Pixabay</a>.
This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.

Long Ideas

Short Ideas

Technicals

Trading Ideas

ETFs

AAPL

AIBD

AIBU

ASAN

MSFT

NVDA

A Digitalization Showdown Offers Traders A Potential Opportunity In Direxion's AI And Big Data Bull And Bear ETFs

Instead, a Senior Vice President in charge of coordination and management of synergistic projects between China and US and management of certain key projects was created. Wei (Larry) Zhang was appointed as the Senior Vice President.

Management

CASI

CASI Pharma Says Position Of President Of The Company Was Removed, Effective From September 10, 2024

KZIA

Kazia Therapeutics shares are trading higher after the company announced that it executed a licensing agreement with QIMR Berghofer Medical Research Institute.

ISPC

iSpecimen shares are trading lower after the company announced a 1-for-20 reverse stock split.

CSBR

Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. Also, Craig-Hallum upgraded the stock from Hold to Buy and maintained its $6 price target.

SYRA

Syra Health shares are trading lower after the company priced a $2.1 million public offering.

BTIG analyst Ryan Zimmerman maintains Alcon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALC#NYSE">ALC</a>) with a Buy and raises the price target from $98 to $104.

BTIG Maintains Buy on Alcon, Raises Price Target to $104

NITO

N2OFF shares are trading higher after the company announced a potential 10% increase in capacity for its Solar PV Joint Venture Project with Solterra Renewable Energy.

The Nasdaq 100 closed higher by over 400 points during Wednesday's session. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Below is a look at a few recent notable insider sales. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Upstart Holdings</h3>
<ul>
<li>The Trade: Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) CFO Sanjay Datta <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 1,500 shares</a> at an average price of $34.85. The insider received around $52,275 from selling those shares.</li>
<li>What's Happening: On Aug. 20, JP Morgan analyst Reginald Smith maintained Upstart with an Underweight and raised the price target from $27 to $30.</li>
<li>What Upstart Does: Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform.</li>
</ul>
<h3 class="wp-block-heading">Zillow Group</h3>
<ul>
<li>The Trade: Zillow Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>) President, Zillow Susan Daimler <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 6,031 shares</a> at an average price of $54.16. The insider received around $326,658 from selling those shares.</li>
<li>What's Happening: On Sept. 6, JMP Securities analyst Nicholas Jones reiterated Zillow with a Market Outperform and maintained a $62 price target.</li>
<li>What Zillow Group Does: Zillow Group Inc is an Internet-based real estate company that offers its customers an on-demand experience for selling, buying, renting, or financing with transparency and ease.</li>
</ul>
<h3 class="wp-block-heading">Intuit</h3>
<ul>
<li>The Trade: Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) EVP, Chief Technology Officer Alex G. Balazs <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 2,941 shares</a> at an average price of $628.76. The insider received around $1.85 million from selling those shares.</li>
<li>What's Happening: On Aug. 22, Intuit reported better-than-expected fourth-quarter financial results and issued FY25 EPS guidance above estimates. Also, the company approved a new $3 billion repurchase authorization.</li>
<li>What Intuit Does: Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte).</li>
</ul>
<h3 class="wp-block-heading">Insulet</h3>
<ul>
<li>The Trade: Insulet Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>) Director Timothy J Scannell <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 5,000 shares</a> at an average price of $225.84. The insider received around $1.1 million from selling those shares.</li>
<li>What's Happening: On Aug. 26, Insulet said its Omnipod is now indicated for use by people with type 2 diabetes in the US..</li>
<li>What Insulet Does: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use.</li>
</ul>
Check This Out:<a href="https://www.benzinga.com/top-stories/24/09/40813043/jim-cramer-not-the-time-to-own-oil-when-asked-about-exxon-mobil-says-ibm-is-performing-well"> </a>
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/09/40813043/jim-cramer-not-the-time-to-own-oil-when-asked-about-exxon-mobil-says-ibm-is-performing-well">Jim Cramer: &#8216;Not The Time To Own Oil,&#8217; When Asked About Exxon Mobil; Says IBM Is &#8216;Performing Well&#8217;</a></li>
</ul>

Insider Trades

Markets

INTU

PODD

UPST

Upstart, Insulet And 2 Other Stocks Executives Are Selling

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page.</a>
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/64cba32c0a40e5000113e0cf/jeff-lick">Stephens &amp; Co. analyst Jeff Lick i</a>nitiated coverage on AutoNation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) with an Overweight rating and announced a price target of $210. AutoNation shares fell 0.2% to close at $158.67 on Wednesday. <a href="https://www.benzinga.com/quote/AN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JMP Securities analyst Trevor Walsh initiated coverage on Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) with a Market Perform rating. Rocket Lab shares gained 8.6% to close at $6.68 on Wednesday. <a href="https://www.benzinga.com/quote/RKLB/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/61aa12038d115900012d093d/steven-shemesh">RBC Capital analyst Steven Shemesh </a>initiated coverage on Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) with a Sector Perform rating and announced a price target of $107. Sprouts Farmers Market shares fell 0.8% to close at $100.70 on Wednesday. <a href="https://www.benzinga.com/quote/SFM/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59ee0921efacff0001caaebe/dae-gon%20ha">Stifel analyst Dae Gon Ha</a> initiated coverage on Inozyme Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INZY#NASDAQ">INZY</a>) with a Buy rating and announced a price target of $16. Inozyme Pharma shares fell 1% to close at $5.21 on Wednesday. <a href="https://www.benzinga.com/quote/INZY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stephens &amp; Co. analyst Jeff Lick initiated coverage on Group 1 Automotive, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPI#NYSE">GPI</a>) with an Equal-Weight rating and announced a price target of $394. Group 1 Automotive shares fell 2% to close at $340.14 on Wednesday. <a href="https://www.benzinga.com/quote/GPI/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying AN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="522" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/12074224/image-99-1024x522.png" alt="" class="wp-image-544323" style="width:561px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/12074224/image-99-1024x522.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/12074224/image-99-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/12074224/image-99-768x392.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/12074224/image-99.png 1317w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:<a href="https://www.benzinga.com/top-stories/24/09/40813043/jim-cramer-not-the-time-to-own-oil-when-asked-about-exxon-mobil-says-ibm-is-performing-well"> </a>
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/09/40813043/jim-cramer-not-the-time-to-own-oil-when-asked-about-exxon-mobil-says-ibm-is-performing-well">Jim Cramer: &#8216;Not The Time To Own Oil,&#8217; When Asked About Exxon Mobil; Says IBM Is &#8216;Performing Well&#8217;</a></li>
</ul>

INZY

RKLB

This AutoNation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

AURA

Aura Biosciences shares are trading higher after the company announced Phase 2 end of study results evaluating bel-sar for the first-line treatment of early-stage choroidal melanoma.

William Blair analyst Max Smock reiterates Simulations Plus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLP#NASDAQ">SLP</a>) with a Outperform.

Reiteration

William Blair Reiterates Outperform on Simulations Plus

Oxford Industries shares are trading lower following worse-than-expected Q2 financial results.

CURV

Torris Holdings shares are trading lower after the company announced the pricing of a public offering of 8 million shares at $4.00 per share to be sold by certain stockholders.

The partnership aims to empower Saudi Arabia to adopt and innovate with gen AI at scale, helping the Kingdom address the evolving digital talent requirement across industries and contribute to the Kingdom&rsquo;s Vision 2030.

Contracts

Aramco Digital, Accenture Form Strategic Partnership To Fuel Generative AI Innovation, Supercharge Digital Skilling Agenda In Saudi Arabia

XCHG shares are trading lower amid possible post-IPO volatility.

Crossing The Frontier Of Emerging Markets Debt

Fixed Income Perspectives: Looking Ahead At Q3 2024 - A Resilient U.S. Economy Is Keeping Rate Cuts On Hold... For Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

News

Latest news for (OTC:JEMTF) Stock